投資評等
最後更新日期：2024/4/27
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2013/10/18 | Deutsche Bank | Hold >> Buy | $49 >> $56 |
| 2013/1/23 | Canaccord Genuity | Hold >> Buy | 50 |
| 2011/3/28 | Robert W. Baird | Neutral >> Outperform | $36 >> $42 |
| 2010/10/12 | Argus | Hold >> Buy | 39 |
| 2010/2/9 | Bernstein | Underperform >> Mkt Perform | |
| 2009/10/27 | Wells Fargo | Market Perform >> Outperform | |
| 2005/8/24 | Wachovia | Underperform->Mkt Perform | |
| 2005/1/21 | Deutsche Securities | Hold->Buy | |
| 2004/10/28 | Morgan Keegan | Mkt Perform->Outperform | |
| 2004/6/14 | Kaufman Bros | Hold->Buy | 40 |
| 2004/3/3 | AG Edwards | Hold->Buy | |
| 2004/2/24 | Morgan Stanley | Equal-weight->Overweight | |
| 2003/12/16 | Banc of America Sec | Neutral->Buy | $38 |
| 2003/10/22 | Deutsche Securities | Hold -> Buy | |
| 2003/10/21 | Wachovia | Underperform -> Mkt Perform | |
| 2003/6/13 | Friedman Billings | Underperform -> Outperform | |
| 2003/2/21 | CSFB | Neutral -> Outperform | 42 |
| 2003/1/30 | Soundview Technology | Neutral -> Outperform | 43 |
| 2003/1/29 | Morgan Stanley | Equal-weight -> Overweight | |
| 2003/1/29 | Lehman Brothers | Equal-weight -> Overweight | |
| 2003/1/28 | Legg Mason | Sell -> Hold | |
| 2003/1/27 | UBS Warburg | Reduce -> Neutral | 32 |
| 2003/1/24 | Deutsche Securities | Hold -> Buy | |
| 2003/1/24 | AG Edwards | Sell -> Hold | |
| 2002/10/8 | Thomas Weisel | Mk -> Rerform -> Attractive | |
| 2002/8/1 | Raymond James | Underperform -> Mkt Perform | |
| 2002/8/1 | Legg Mason | Hold -> Buy | 40 |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2014/12/9 | Robert W. Baird | Outperform >> Neutral | $54 >> $50 |
| 2014/1/22 | Pacific Crest | Outperform >> Sector Perform | |
| 2013/1/14 | UBS | Buy >> Neutral | $48 >> $44 |
| 2011/1/12 | Deutsche Bank | Buy >> Hold | $35 >> $36 |
| 2010/7/1 | Standpoint Research | Buy >> Hold | |
| 2010/2/4 | Credit Suisse | Outperform >> Neutral | $32 >> $30 |
| 2010/1/28 | Argus | Buy >> Hold | |
| 2010/1/27 | FBR Capital | Outperform >> Mkt Perform | $37 >> $34 |
| 2009/9/16 | UBS | Buy >> Neutral | |
| 2006/10/9 | Citigroup | Hold Sell | |
| 2006/8/15 | Rochdale Securities | Buy Hold | |
| 2005/5/4 | CIBC Wrld Mkts | Sector Outperform->Sector Perform | |
| 2005/1/20 | Smith Barney Citigroup | Buy->Hold | |
| 2005/1/19 | Morgan Stanley | Overweight->Equal-weight | |
| 2005/1/13 | CSFB | Outperform->Neutral | |
| 2005/1/13 | Robert W. Baird | Outperform->Neutral | |
| 2005/1/12 | Goldman Sachs | Outperform->In-Line | |
| 2004/9/15 | Deutsche Securities | Buy >> Hold | |
| 2003/9/24 | Morgan Keegan | Outperform -> Mkt Perform | |
| 2003/6/13 | Thomas Weisel | Outperform -> Peer Perform | |
| 2003/4/3 | Morgan Stanley | Overweight -> Equal-weight | |
| 2003/1/8 | AG Edwards | Hold -> Sell | |
| 2003/1/8 | Legg Mason | Hold -> Sell | |
| 2003/1/8 | UBS Warburg | Hold -> Reduce | |
| 2003/1/7 | Lazard Freres | Hold -> Sell | |
| 2002/11/6 | Credit Lyonnais Sec | Add -> Hold | 37 |
| 2002/11/4 | Legg Mason | Buy -> Hold | |
| 2002/11/1 | Lehman Brothers | Overweight -> Equal-weight | |
| 2002/10/23 | Bear Stearns | Outperform -> Ree -> Rerform | |
| 2002/10/23 | Morgan Stanley | Overweight -> Equal-weight | |
| 2002/8/20 | UBS Warburg | Buy -> Hold | 50 |
| 2002/7/23 | Dresdner Klnwrt Wass | Add -> Hold | |
| 2002/7/22 | Merrill Lynch | LT Buy -> LT Neutral | |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2013/5/17 | Barclays | Overweight | 59 |
| 2012/11/15 | National Securities | Buy | 50 |
| 2012/3/27 | Canaccord Genuity | Hold | 36 |
| 2010/3/19 | Standpoint Research | Buy | 37 |
| 2010/1/7 | Jefferies & Co | Buy | 37 |
| 2009/10/23 | Credit Suisse | Outperform | 32 |
| 2009/6/18 | Pali Research | Buy | 39 |
| 2009/4/24 | Piper Jaffray | Neutral | |
| 2009/4/24 | Auriga U.S.A | Buy | 40 |
| 2006/7/18 | Prudential | Underweight | 31 |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 2014/2/24 | Barclays | Overweight | 55 |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2013/8/22 | Telsey Advisory Group | Not Rated | $55 >> $52.50 |
| 2013/7/17 | Deutsche Bank | Hold | $47 >> $49 |
| 2012/7/20 | Hilliard Lyons | Buy | $45 >> $47 |
| 2012/5/14 | Canaccord Genuity | Buy | $36 >> $41 |
| 2011/1/26 | RBC Capital Mkts | Outperform | $35 >> $39 |
| 2010/10/26 | Hilliard Lyons | Buy | $32 >> $34 |
| 2010/10/25 | RBC Capital Mkts | Outperform | $33 >> $35 |
| 2010/10/19 | Barclays Capital | Equal Weight | $31 >> $34 |
| 2010/10/8 | Auriga U.S.A | Hold | $29 >> $33 |
| 2009/10/27 | Auriga U.S.A | Hold | $34 >> $31 |